VIVA BIOTECH HOLDINGSVIVA BIOTECH HOLDINGSVIVA BIOTECH HOLDINGS

VIVA BIOTECH HOLDINGS

No trades
See on Supercharts
Market capitalization
‪955.26 M‬HKD
−0.060HKD
‪−128.30 M‬HKD
‪2.38 B‬HKD
‪1.32 B‬
Beta (1Y)
1.51

About VIVA BIOTECH HOLDINGS

CEO
Chen Mao
Headquarters
Shanghai
Employees (FY)
‪2.08 K‬
Founded
2008
ISIN
KYG9390W1015
FIGI
BBG00NZ74JJ9
Viva Biotech Holdings engages in the discovery, development, and manufacturing of clinical drugs. It operates through Drug Discovery, and Contract Development Manufacture Organisation (“CDMO”) and Commercialization segments. The Drug Discovery segment involves in structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage innovative drug development. The Contract Development Manufacture Organisation (“CDMO”) and Commercialization segment consists of contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations. The company was founded by Feng Mao Hua, Chen Cheney Mao and Ying Wu on August 27, 2008 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1873 is 0.440 HKD — it has decreased by 1.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange VIVA BIOTECH HOLDINGS stocks are traded under the ticker 1873.
VIVA BIOTECH HOLDINGS is going to release the next earnings report on Aug 26, 2024. Keep track of upcoming events with our Earnings Calendar.
1873 stock is 8.33% volatile and has beta coefficient of 1.51. Check out the list of the most volatile stocks — is VIVA BIOTECH HOLDINGS there?
Yes, you can track VIVA BIOTECH HOLDINGS financials in yearly and quarterly reports right on TradingView.
1873 stock has fallen by 10.20% compared to the previous week, the month change is a 18.52% fall, over the last year VIVA BIOTECH HOLDINGS has showed a 73.33% decrease.
1873 net income for the last quarter is ‪−126.54 M‬ HKD, while the quarter before that showed ‪1.15 M‬ HKD of net income which accounts for ‪−11.14 K‬% change. Track more VIVA BIOTECH HOLDINGS financial stats to get the full picture.
Today VIVA BIOTECH HOLDINGS has the market capitalization of ‪953.09 M‬, it has decreased by 7.69% over the last week.
Like other stocks, 1873 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIVA BIOTECH HOLDINGS stock right from TradingView charts — choose your broker and connect to your account.
1873 reached its all-time high on Jun 23, 2021 with the price of 11.640 HKD, and its all-time low was 0.455 HKD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪2.08 K‬ employees. See our rating of the largest employees — is VIVA BIOTECH HOLDINGS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIVA BIOTECH HOLDINGS technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIVA BIOTECH HOLDINGS stock shows the sell signal. See more of VIVA BIOTECH HOLDINGS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIVA BIOTECH HOLDINGS EBITDA is ‪443.11 M‬ HKD, and current EBITDA margin is 18.53%. See more stats in VIVA BIOTECH HOLDINGS financial statements.